NeuroSynergy 2025

NeuroSynergy 2025 is organized by AdventHealth Nicholson Center and will be held on Jun 12, 2025, at AdventHealth Nicholson Center, Celebration, Florida, United States of America.

Course Overview:
This two-day conference gives the platform to have open dialogue, discussion, and debate about the etiology, progression, and therapeutic approaches for a better understanding of cognitive wellness. This event will host interactive courses that will allow time for Q&A after each lecture, and we will encourage active participation using the audience response/polling system to incorporate a self-assessment where participants can see how their answer choices compare to their peers. There will be smaller group breakout sessions for participants to attend creating a lively, respectful atmosphere, and engaging scientists, and clinicians around the topics of Neurosciences in multiple capacities. We will be featuring didactic/case presentations and poster sessions led by experts in neuroscience and related fields. Specifically, this event focuses on current advances in biomarker assessment, treatment with medication interventions, and prevention of neurodegenerative diseases, such as Dementia of Alzheimer’s disease, parkinsonism, multiple sclerosis, and neuromuscular diseases, Additional topics of the symposium include impacts of sleep, Normal Pressure Hydrocephalus, epilepsy, and research trials.

Course Objectives:

• Determine effective clinical strategies in the management of Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson’s, and headaches/migraines.
• Identify early and progressive signs of disorders associated with aging, including Dementia, Alzheimer’s, and Parkinson’s.
• Discuss current research developments and treatment options specific to neurological diseases in both common and complex clinical cases.
• Analyze how lifestyle choices, genetic predispositions, and etiological factors contribute to the onset of neurological diseases.
• Determine effective clinical strategies for treating neurological disorders, including strokes, Polyneuropathy, and neurological pain.
• Discuss research developments in clinical cases involving the identification and management of Multiple Sclerosis (MS), Epilepsy, and neuroimmunology disease.
• Identify the value and importance of each team member’s role in the treatment of neurological disorders, including neurology consultations performed by Advanced Practice Providers (APPs).
• Identify recent treatment innovations and the best practices in diagnostic testing for neurodegenerative diseases and neurological disorders.